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RNA polymerase II contains a long C-terminal domain (CTD) that
regulates interactions at the site of transcription. The CTD
architecture remains poorly understood due to its low sequence
complexity, dynamic phosphorylation patterns, and structural
variability. We used integrative structural biology to visualize
the architecture of the CTD in complex with Rtt103, a 3′-end RNA-
processing and transcription termination factor. Rtt103 forms
homodimers via its long coiled-coil domain and associates densely
on the repetitive sequence of the phosphorylated CTD via its
N-terminal CTD-interacting domain. The CTD–Rtt103 association
opens the compact random coil structure of the CTD, leading
to a beads-on-a-string topology in which the long rod-shaped
Rtt103 dimers define the topological and mobility restraints of
the entire assembly. These findings underpin the importance of
the structural plasticity of the CTD, which is templated by a par-
ticular set of CTD-binding proteins.
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The C-terminal domain (CTD) of the largest subunit of RNApolymerase II (RNAPII) consists of multiple tandem repeats
(26 in yeast, 52 in humans) of the heptapeptide consensus Tyr1-
Ser2-Pro3-Thr4-Ser5-Pro6-Ser7, which is highly conserved
from yeast to human (1–3). The CTD serves as a binding
platform for many RNA/protein-binding factors involved in the
regulation of the transcription cycle (1, 3). Yeast are inviable if
the CTD is trimmed to less than 11 repeats of the heptapeptide
consensus (4) or if the periodicity of two repeats is perturbed
(5), suggesting the importance of both the CTD length and its
repetitiveness.
The CTD interaction network is regulated by posttranslational
modifications of the CTD, which yield specific phosphorylation
and subsequent factor-binding patterns in coordination with the
transcription cycle (the “CTD code”) (1, 6–11). Phosphorylations
at Y1, S2, T4, S5, and S7 are the most common and well-studied
posttranslational modifications of the CTD (12). Mass spec-
trometry studies of the CTD showed that the CTD heptads are
homogeneously phosphorylated along the entire length of the
domain in proliferating yeast and human cells (13, 14). Major
phosphorylation sites are S2 and S5, whereas Y1, T4, and S7 are
minor phosphorylation sites (13, 14), but all sites are important
for transcription regulation and proper functioning of the cell.
On average, each CTD heptad is phosphorylated once and the
occurrence of two phosphorylations per repeat is a rare event
(13, 14). The coimmunoprecipitation of specific CTD phos-
phoisoforms revealed distinct functional sets of factors (CTD-
interactome) related to each CTD phosphoisoform (15).
The CTD has no well-defined 3D structure and, therefore, is
not observed in the crystal structures of RNAPII (16–19) and
forms fuzzy densities on electron microscopy images (20, 21).
Nevertheless, the first structural information of the unbound
CTD has recently been reported in the fruit fly (22, 23), where it
was shown that the CTD forms a compact random coil and that
its phosphorylation induces a modest extension and stiffening of
the CTD (22, 23).
Current structural knowledge of interactions between the
CTD and its recognition factors is based on short peptides
mimicking the CTD bound to given CTD binding factors (1, 19,
24). However, the atomic-level structural architecture of the full-
length CTD modulated by associated factors remains unknown.
Several studies attempted to propose a structural model for the
full-length CTD. For example, in the complex of the CTD peptide
with the CTD-interacting domain (CID) of Pcf11, a subunit of
cleavage factor IA (25), the CTD heptad was found to adopt a
β-turn conformation (26). Therefore, a compact, left-handed,
β-spiral model of the CTD was proposed (26). A β-spiral confor-
mation would allow the CTD chain with a length of 100 Å to
fold into a compact structure, which corresponds to the ob-
served densities in low-resolution electron microscopy images of
RNAPII (20). The heterodimer composed of the human proteins
RPRD1A and RPRD1B was found to bind the CTD, thereby
stimulating the recruitment and phosphatase activity of RPAP2
(pS5-CTD-phosphatase) (27). These findings led to the proposal of
a model in which the CTD and accessory molecules form a
high-order arrangement dubbed the “CTDsome” (27).
To probe the CTDsome architecture experimentally, we set
out to apply integrative structural biology methods and investi-
gate how the termination factor Rtt103 decorates the sequence
of the CTD. First, we independently solved high-resolution
structures of stable subunits by solution NMR spectroscopy
(NMR) and X-ray crystallography. Then, we corroborated the
obtained structural information with small-angle X-ray scattering
(SAXS) data to reconstruct the overall architecture of the
Rtt103–CTD complex. We show that Rtt103 contains a coiled-
coil domain that mediates Rtt103 dimerization and uses its
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N-terminal CID to read adjacent repetitive phosphorylation
marks on the CTD independently of one other. Our reconstruction
demonstrates how Rtt103 explores the repetitiveness and length
of the CTD sequence while keeping the entire arrangement
partially flexible.
Results
Limited Proteolysis of Rtt103 Reveals a Coiled-Coil Domain That
Mediates Dimerization. In our divide-and-conquer approach, we
first identified the overall domain organization of Rtt103. Trypsin
digestion of the full-length Rtt103 coupled with mass spectrometry
revealed that the protein fragment harboring amino acid residues
1–246 (Rtt1031–246) is protected from proteolytic cleavage (Fig. 1A
and Fig. S1). The remaining C-terminal part of Rtt103 (amino acid
residues 247–409) was efficiently digested by trypsin, suggesting the
absence of additional structured domains (Fig. 1A and Fig. S1).
Subsequent biochemical characterization of the identified stable
constructs revealed that Rtt103141–246 and Rtt1031–246 form homo-
dimers (Fig. S2 A and B). Subsequent crystallization screens of the
Rtt103141–246 and Rtt1031–246 constructs showed that only
the Rtt103141–246 construct formed well-diffracting crystals. The









































































Fig. 1. Dimerization and RNAPII CTD recognition by Rtt103. (A) Scheme of Rtt103 domain organization (Upper). The numbers below the scheme represent
borders of the amino acid segments. Structured and flexible regions were determined based on the limited proteolysis study (Fig. S1). The recombinant
protein constructs used in the study, along with their respective molecular masses, are shown (Lower). CID, CTD-interacting domain; polyD, polyaspartate
stretch. (B) Crystal structure of the Rtt103141–246 coiled-coil domain shown superimposed with an ab initio model (gray mesh) derived using DAMMIN (40) from
SAXS scattering data. The two different polypeptide chains of the coiled-coil dimer are shown in red and blue; their respective N- and C-termini, as well as
α-helices, are indicated. (C) Electrostatic surface representation of the Rtt103 CID (electropositive in blue, electronegative in red, neutral in white) in complex
with the pS2pS7-CTD peptide (yellow sticks; PDB ID code: 5M9D). The N- and C-termini of the peptide are indicated. Dashed black circles indicate electro-
positive areas that accommodate pS7 residues. (D) Detailed view of the Rtt103 CID (gray cartoons) bound to the pS2pS7-CTD peptide (yellow sticks). High-
lighted Rtt103 CID residues (gray sticks, blue labels) form hydrophobic contacts and putative hydrogen bonds with the pS2pS7-CTD peptide (yellow sticks,
black labels). The sequence of the peptide used for structure determination is indicated above; residues that showed interaction with the Rtt103 CID are
shown in black and red.
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(Tables S1 and S2). We found that each Rtt103141–246 subunit
consists of two α-helices, namely the α1-helix (Gln146-Glu177)
with a small bend in the middle and a long α2-helix of ∼105 Å in
length (Val184-Asp246) (Fig. 1B). In the crystal, two protein
chains form a dimer where the α2-helices are arranged in an
antiparallel fashion (Fig. 1B). This architecture of the dimer is in
agreement with findings from gel filtration experiments (Fig.
S2A) and SAXS data (Fig. S2B). Importantly, the central region
of the α2-helix (Lys200-Ile238) contains a coiled-coil signature,
which is arranged in trans in the antiparallel dimer assembly of
the two Rtt103 molecules. The coiled-coil domain contains a
characteristic knobs-into-holes packing with mixed “a” and “d”
layers (Fig. S2C), with an average pitch of 172 Å (defined by
CCCP; ref. 28). The dimer structure is also stabilized by multiple
intermolecular (Asp149-Lys152, Asp153-Lys216, Lys168-Asp172,
Asp223-Arg226) and intramolecular (Lys200-Glu239, Glu231-
Arg210-Glu224) salt bridges. Altogether, the key findings re-
garding Rtt103 architecture are as follows: (i) Rtt103 contains a
coiled-coil domain that follows the CID and (ii) the C-terminal
half of the Rtt103 is disordered.
The Rtt103 CID Binds the Extended pS2-pS7-CTD Peptide. The struc-
ture of Rtt1031–131 (or CTD-interacting domain; CID) bound to
a short Ser2-phosphorylated CTD moiety has previously been
reported (29). Here, we used NMR to determine the structure of
Rtt1031–131 bound to a longer CTD substrate (Ser2/7-phosphorylated;
Tables S3 and S4), which revealed that the recognition interface
of the CID is, in fact, larger than previously reported (29). Our
NMR structure of Rtt1031–131 bound to the extended TSPpS7
YpS2PTSPpS7 YpS2PTS peptide (termed pS2pS7-CTD) con-
firmed the previously reported observation regarding the recog-
nition of the upstream region of pS2pS7-CTD, and further revealed
information regarding the recognition of the downstream region of
pS2pS7-CTD (Fig. 1 C and D). The structure of Rtt103 CID is
formed by eight α-helices in a right-handed superhelical arrange-
ment. The NMR data show that the pS2pS7-CTD peptide binds at
the conserved surface formed by helices α2, α4, and α7 of the
Rtt103 CID (Fig. 1D and Fig. S3). NMR revealed intermolecular
contacts between Rtt1031–131 and the residues P6a, pS7a, Y1b, pS2b,
P3b, T4b, S5b, and Y1c of the pS2pS7-CTD peptide. Specifically, P6a
lies in the proximity of the hydrophobic area formed by the
N-terminal tip of the α2-helix, being involved in multiple intermo-
lecular contacts with Ser18, Gln19, and Glu20. Residue Y1b is also
docked into a hydrophobic pocket (Ile22, Tyr62) and stabilized by
a hydrogen bond between its hydroxyl group and the side-chain
amide group of Asn65. Residue P3b forms hydrophobic interac-
tions with Val109 and Ile112. Residues pS2bP3bT4bS5b form a
β-turn stabilized by hydrogen bonds between the pS2b carbonyl and
the S5b amide, between the pS2b γ-oxygen and T4b amide, and
between the pS2b phosphate and T4b hydroxyl. Perturbation of the
above-described hydrophobic pocket (not affecting the structural
integrity; Fig. S4C and refs. 27 and 30) caused a drop of 30- to 50-
fold in the affinity between pS2pS7-CTD and Rtt1031–131 (KD =
33 ± 1.2 μM for Ile112Ala, KD = 80 ± 11 μM for Ile112Gly) (Fig.
S4). In agreement with previous structural observations (29), we
noted that the phosphorylation of S2b is recognized by the side
chain of Arg108. Interestingly, we observed multiple close contacts
between Y1c and the C-terminal parts of helices α4 and α7. The
positioning of Y1c near the tip of helices α4 and α7 induces a
second sharp turn in the pS2pS7-CTD peptide. The side chain of
Y1c forms a broad range of hydrophobic contacts with Lys72,
Gly73, and Ile118, whereas the guanidinium group of Arg116
coordinates the backbone of pS2pS7-CTD. We found that charge-
swapping mutations at the interacting sites of Rtt103 (not affect-
ing the structural integrity; Fig. S4C) resulted in pronounced af-
finity decrease between Rtt103 and pS2pS7-CTD (KD = 9.7 ± 0.7,
51 ± 2.2, and 65 ± 8.9 μM for Lys72Glu, Arg116Glu, and
Lys72Glu/Arg116Glu, respectively), highlighting the importance
of the CTD backbone interactions with Arg116. A large area of
the Rtt103 CID surface is positively charged and enriched in
residues that could stabilize interaction with negatively charged
sites of the phosphorylated CTD peptide (Fig. 1C). Although our
data did not indicate the presence of intermolecular contacts for
the pS7 residues, the positions of these residues are indirectly
defined by the nuclear Overhauser effects from the neighboring
residues. Therefore, residues pS7 are likely involved in charge–
charge interactions with Lys27 and Lys105 (which is part of the
poly-Lys tract Lys103-Lys104-Lys105) (Fig. 1C). We found that
the Lys27Glu mutant (perturbation of one of the pS7 binding
pockets; Fig. 1C) showed lower binding only for the pS7 con-
taining peptide (KD of 13.2 ± 0.3 μM and 28.5 ± 1 μM for wild
type and Lys27Glu, respectively) but not for the pS2-containing
peptide (KD of 1.6 ± 0.07 μM and 2 ± 0.8 μM for wild type and
Lys27Glu, respectively). Altogether, the key finding is that the
Rtt103 CID interacts with pS2pS7-CTD via a larger area than
previously reported (29), specifically recognizing the down-
stream region of the CTD peptide. Our structure reveals that
P6apS7aY1bpS2bP3bT4bS5bP6bpS7bY1c is the minimal CTD-binding
moiety recognized by Rtt103.
Two CIDs Tethered by a Coiled-Coil Domain Tumble Independently.
As a result of the antiparallel arrangement of the coiled coils, the
Rtt103 CIDs are attached by a linker of 15 amino acids to the
middle region of the coiled-coil domain. NMR investigations of
the Rtt1031–246 and CID constructs showed that the CID struc-
ture is not influenced by the presence of the coiled-coil domain
and that the CIDs are likely to tumble independently (Fig. S5).
To visualize the arrangement of the Rtt103 CIDs relative to the
coiled-coil domains, we analyzed SAXS scattering data of puri-
fied Rtt1031–246 using available atomic structures (PDB ID
codes: 2KM4, 5M48) by ensemble-optimization method (EOM
2.0) (31). This approach enables deconvolving the conforma-
tional averaging into the contribution of individual conformers.
The obtained models suggest that the coiled-coil domain de-
fines the length of the protein (∼105 Å) (Fig. 2), and the linker
allows the CIDs to reach all across the 105-Å-long coiled-coil
domain. Thus, the CIDs could be positioned relatively close to
each other but are also able to sample a large surrounding space
to recognize the substrate (Movie S1). Next, we tested whether the
coiled-coil–mediated dimerization of Rtt103 affects the binding
to the CTD using fluorescence anisotropy (FA). We measured
the binding affinity for the minimal CTD-binding moiety (SPS
YpSPTSPpS YS) and a long CTD substrate (harboring two min-
imal CTD-binding moieties connected with a spacer; SPS
YpSPTSPpS YSPTSPS YpSPTSPpS YS) with Rtt1031–246 and
with the CID. We found that Rtt1031–246 binds to the minimal
CTD-binding moiety with a KD of 3.3 ± 0.06 μM, and to the
long CTD substrate with a KD of 0.3 ± 0.01 μM. The isolated
CID binds to the minimal CTD-binding moiety with a KD of 1.65 ±
0.13 μM, and to the long CTD substrate with a KD of 0.5 ± 0.01 μM.
This suggests that the dimerization increases the local concentration
of CIDs that are available for the CTD binding. Altogether, the key
finding is that dimerization of the Rtt103 coiled-coil domains does
not promote formation of a rigid structure between the Rtt103
CIDs, but in fact helps the CIDs sample multiple conformations
restricted only by their tethering to the flexible linker.
The Rtt103 Coiled-Coil Domain Restricts the Variability of the CTD–
CIDs Assembly. Next, we asked whether the coiled-coil-mediated
dimerization of Rtt103 affects the overall fashion in which the
repetitive CTD sequence is decorated with Rtt103 CIDs. The
complex between Rtt1031–246 and pS2E-CTD {pSer2-CTD mimic
[SPEFTCEPTSPS-(YEPTSPS)13-YEPAAADYKDDDDK]; Fig.
S6} was prepared by mixing individual proteins with molar excess
of Rtt1031–246, followed by size-exclusion chromatography and
SAXS data collection. The estimation of the molecular mass








(MM) of the complex was done using DAMMIF (32), which
yielded a MM of 200 ± 5 kDa, that is close to the theoretical MM
of the Rtt1031–246:CTD complex with a ratio of 6:1 (190 kDa). In
terms of molecular architecture, it suggests that three Rtt103
dimers bind to a 13-repeat-long CTD upon saturation. The in-
terpretation of the scattering data was performed using the
CORAL software (33). The structures of the Rtt103 CID (PDB
ID code: 5M9D) and coiled-coil domain (PDB ID code: 5M48)
were combined together with the distance constraints between
the CTD and Rtt103 CID and fitted against the experimental
SAXS data. The calculation was repeated 10 times for each in-
teraction scenario with a ratio of 6:1 for Rtt1031–246:CTD, which
provided the best fit to the experimental data (Fig. 3 and Fig.
S7). All reconstituted complexes displayed a similar elongated
architecture characterized by a Dmax value of 180–250 Å (Fig.
S7B). One Rtt103 dimer is accommodated on four CTD repeats
(PS YEPTSPS YEPTSPS YEPTSPS YEPTS; CID recognition
sites are shown in bold). In this architecture, the coiled-coil
domains surround the individual Rtt103 CIDs accommodated on
the CTD (Fig. 3). The shielding provided by the coiled coils
restricts the flexibility of CIDs on the CTD to some extent, but
promotes the stretching of the compact random coil structure of
the CTD (22, 23). Interestingly, we obtained a similar quality fit
to the experimental data without including the constraint that
two CIDs of the dimer must bind neighboring CTD epitopes
(Fig. S7). The obtained models contain CIDs accommodated in
different areas of the CTD, supporting the hypothesis of residual
flexibility in the core of the CTDsome shielded from the outside
by coiled coils. Altogether, the key finding is that the CTDsome
architecture is dynamic and allows for optimal recognition of
available phosphorylation signals in the CTD. This variability is
essential as the CTD contains some poorly conserved heptads (2)
whose recognition is promoted by dimerization in which the
coiled-coil domains prime the sampling of the CTD epitopes
(Fig. 3 and Fig. S7).
Discussion
Assembly and reassembly of the CTDsome during transcription
by RNAPII is important for regulation of transcription and RNA
processing. However, due to the structural complexity and dy-
namics of the CTDsome, the mechanistic aspects of this process
remain poorly understood. Here, we report an experimentally
based structural model of the CTDsome, which has been derived
using a combination of X-ray, NMR, and SAXS data (Fig. 3).
First, we determined that Rtt103 is capable of dimerizing in
free form via a coiled-coil domain. Several CID-containing
proteins are known to have multimerization regions such as the
Nrd1-Nab3 heterodimerization region (34), coiled-coil region in
Pcf11 (35), and coiled-coil regions in RPRD1A, RPRD1B, and
RPRD2 (27, 36). The RPRD1A-RPRD1B heterodimer binds to
multiple pS2-CTD repeats and exposes the pS5 sites on the CTD,
which stimulates the activity of RPAP2 pS5-CTD phosphatase. It
is likely that the Rtt103 scaffold is used to recruit other factors or
enzymes (e.g., Rat1-Rai1) that act on the CTD. In contrast to
RPRD1A and RPRD1B, which include only the CID and di-
merization domain, Rtt103 has a long unstructured C-terminal
part that occupies half of the protein and, therefore, could greatly
impact multisubunit architectures and interactions with other
RNA/protein-binding factors.
Here, we determined that the Rtt103 CID binds across three
CTD heptads and that the minimal CTD binding moiety consists
of the P6apS7aY1bpS2bP3bT4bS5bP6bpS7bY1c sequence. These
findings indicate that the Rtt103 CID binds a longer CTD stretch
than previously reported (29). Accommodation of the core
P6aS7aY1bS2bP3bT4bS5b stretch of the CTD in the CID binding
pocket is highly conserved among CID–CTD peptide complexes
(26, 27, 37, 38). In contrast, the conformation of the upstream
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front view side view
Fig. 2. The two Rtt103 CIDs are tethered by a coiled-coil domain but tumble independently. (A) Overlay of individual conformations from the ensemble of
free Rtt1031–246 structures derived using the ensemble-optimization method (EOM 2.0) (31) (χ2 = 1.001); front and side views are provided. Conformations are
superimposed based on structure of the coiled-coil domain. Conformations 2–5 are shown with 60% opacity. The two different polypeptide chains are shown
in red and blue. (B) Individual conformations from the Rtt1031–246 ensemble derived by EOM 2.0; the fraction (%), radius of gyration (Rg), and maximum
intraparticle distance (Dmax) are indicated for each conformation.
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and especially downstream region of the CTD peptide on the
CID surface varies among CID–CTD peptide complexes (26, 27,
37, 38). In our solution NMR structure, the pS2pS7-CTD peptide
makes multiple contacts with a conserved Arg116 residue and
exits the binding pocket between helices α4 and α7, thereby
occupying almost the whole conserved surface of the CID.
Similarly, the solution structure of pT4-CTD–Rtt103-CID and
crystal structure of RPRD1B/RPRD1A also exhibit an elongated
conformation of the CTD (27, 30). In these structures, the
binding of additional residues at the C-terminal of the β-turn
stretch of the CTD significantly changes the conformation of
bound CTD, which could be important for the higher order ar-
rangement of CIDs and exposure of the nonbound CTD residues
to other factors (27). Additionally, the extended interaction surface
of the CIDs in Rtt103 and RPRD1B/RPRD1A may partially
explain their higher affinity toward the CTD compared with the
affinity of the CIDs in Nrd1 and Pcf11 (38, 39).
The regulation of transcription requires a complex interplay
involving fast and dynamic exchange of multiple RNA/protein-
binding factors. This network is largely maintained and balanced
by means of a structurally adaptable CTD which increases the
local concentration of factors and allosterically regulates their
activity of transcription and RNA processing factors near the
emerging nascent transcript. Our reconstruction of the CTD in
complex with Rtt103 shows that Rtt103 can fully explore the
repetitiveness and length of the CTD sequence by occupying
CTD in a repetitive manner (“beads-on-a-string”) while keeping
the entire arrangement flexible and dynamic. Rtt103 dimerization
creates topological and mobility restraints, which, in turn, tune the
protein’s affinity toward the CTD by increasing the local con-
centration of CIDs, and further governs the exposure of the CTD
sequence to other protein-binding factors. We suggest that CTD
code readers, such as Rtt103, and other CTD effector molecules
form a high-order structure that is essential for the conception and
interpretation of the CTD code (Fig. 4 and Movie S2). The tail-
like architecture allows for quick exchange of binding factors and
coordinates the regulatory networks necessary for efficient gene
regulation. Interestingly, the structure of the CTD tail decorated
with Rtt103 dimers appears to be fully extended and protrudes
away from the invariant core of the RNAPII (Fig. 4 and Movie
S2). The structural model of the Rtt103–CTDsome demonstrates
how the CTD allows forming diverse and tuneable protein as-
semblies around the invariant core of the RNAPII, supporting the
complex networks necessary for efficient gene regulation.
Methods
A full description of the methods for protein expression, purification, and
fluorescence anisotropy measurements as well as NMR, X-ray, and SAXS data
collection and analysis is provided in SI Methods and Tables S5 and S6. SAXS
data are deposited in Small Angle Scattering Biological Data Bank (SASBDB ID:
SASDCZ2). The model and the diffraction data containing phase information
was deposited to Protein Data Bank, PDB ID code: 5M48. The atomic coordi-
nates and restraints for the NMR ensemble of the Rtt103-CID—pS2pS7-CTD
complex have been deposited in the Protein Data Bank, PDB ID code: 5M9D.
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Fig. 3. Multisubunit arrangement of Rtt1031–246 across half the length of
the CTD. (A) Comparison of the theoretical scattering (black) derived using
CORAL based on the Rtt1031–246-CTD model against the experimental scat-
tering data (gray). (B) Scheme showing the arrangement of the individual
Rtt1031–246 molecules across half the length of the CTD (13 heptad repeats),
which is the CTD construct employed during modeling using CORAL (con-
secutive interaction, “scenario 0,” see Fig. S7). (C) Representative model
obtained from the CORAL calculation for the consecutive interaction sce-
nario. Color coding is according to the scheme in B.
Fig. 4. Model of the Rtt103-CTDsome assembly involving the full-length
RNAPII CTD. The model of the RNAPII with the full-length CTD is decorated
with six dimers of Rtt1031–246 (Movie S2). The structure of RNAPII (PDB ID
code: 5F12) is combined with two CORAL models of the Rtt1031–246–CTD
complex, where C-interacting domains (CIDs) are arranged in a consecu-
tive manner.
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SI Methods
Cloning and Purification of Phospho-Serine Mimetic. Template for
phospho-serine mimetic was synthesized by GeneArt, Thermo
Fisher Scientific. Sequence was amplified and cloned into pET28b-
SMT3 (41) using BamHI andHindIII restriction sites with the addition
of C-terminal FLAG-tag [protein sequence after 6xHIS-SUMO
cleavage: SPEFTCEPTSPS-(YEPTSPS)13-YEPAAADYKDDDDK].
Resulted construct was verified by DNA sequencing and transformed
into E. coli BL21-Codon Plus (DE3)-RIPL cells (Stratagene). For
protein expression, bacteria was grown in M9 medium with 50 mg/L
of kanamycin at 37 °C until OD600 ∼ 0.6, cooled down to 30 °C,
induced with 0.1 mM IPTG and protein was overexpressed at 30 °C
overnight. Cells were harvested by centrifugation and resuspended
in the denaturing buffer (8 M urea, 50 mM Tris, 500 mM NaCl,
10 mM BME, 5 mM imidazole, 0.1% Nonidet P-40, pH20 °C = 8).
The lysate was rigorously stirred at 4 °C for 1 h, cleared then by
centrifugation (50,000 × g for 1 h). Soluble fraction was loaded on
Ni-NTA beads (Qiagen), the bound protein was refolded on the
column with the refolding buffer (50 mM Tris, 500 mM NaCl,
10 mM BME, 5 mM imidazole, 0.1% Nonidet P-40, pH4 °C = 8),
and eluted with refolding buffer containing 300 mM imidazole.
6xHIS-SUMO-tag was cleaved overnight by Ulp1 protease during
the dialysis into the refolding buffer. Cleaved fraction of 6xHIS-
SUMO-tag was bound to Ni-NTA beads (Qiagen), flow-through
containing was concentrated using Vivaspin 20 (Sartorius) con-
centrator with 3,000 Da cutoff, loaded on Superdex 75 10/600 (GE
Healthcare), and eluted with 50 mM Tris, 500 mM NaCl, 10 mM
BME, pH20 °C = 8 (room temperature).
Cloning and Purification of Rtt103. The pET28b-Rtt103-CID S18A,
Q19A, I112A, and I112G plasmids were gifts from T. Kabzinski,
CEITEC, Brno, Czech Republic. Rtt103-CID-6xHIS point mu-
tants (K72E, K72E/R116E, R108E, R116E) were obtained by
QuikChange site-directed mutagenesis kit (Stratagene). Resulting
constructs were verified byDNA sequencing, and then transformed
into E. coli BL21-Codon Plus (DE3)-RIPL cells (Stratagene).
Rtt103-CID-6xHIS (gift from A. Meinhart, Max Planck Institute
for Medical Research, Heidelberg) and point mutants were
expressed and purified as previously described (29).
pET21b-Rtt103-1–246 was amplified from pET21b-Rtt103 (gift
from C. L. Moore, Tufts University School of Medicine, Boston)
by removing residues 247–409. Rtt103141–246 was amplified from
pET21b-Rtt103 and cloned into pET22b using NdeI and XhoI re-
striction sites. Resulting constructs containing C-terminal 6xHIS-tag
were verified by DNA sequencing and then transformed into E. coli
BL21-Codon Plus (DE3)-RIPL cells (Stratagene).
For the expression of Rtt1031–246, bacterial culture was grown in
M9 medium with 50 mg/L of ampicillin at 37 °C until OD600 ∼ 0.3,
cooled down to 20 °C, induced with 0.5 mM IPTG, and protein
was overexpressed at 20 °C overnight. Cells were harvested by
centrifugation and resuspended in lysis buffer [50 mM KH2PO4,
500 mM KCl, 0.5 mM EDTA, 10 mM BME, 40 mM imidazole,
10% glycerol, pH20 °C = 7 supplemented with protease inhibitor
mixture (cOmplete; Roche)]. After disruption of cells, the lysate
was cleared by centrifugation (50,000 × g for 1 h) and soluble
fraction was loaded on HisTrap FF Crude (GE Healthcare). The
column was washed by lysis buffer containing 75 mM imidazole,
protein eluted by lysis buffer containing 500 mM imidazole. Buffer
was exchanged to the ion-exchange buffer (25 mM KH2PO4,
50 mM KCl, 1 mM BME pH20 °C = 6.5) using HiPrep26/10
desalting (GE Healthcare). Protein was loaded on HiTrap SP HP
column (GE Healthcare) equilibrated with the ion-exchange buffer
and eluted with 50 mM to 1 M KCl gradient. Eluted protein was
further purified on HiLoad Superdex 200 (GE Healthcare) in
25 mM KH2PO4, 300 mM KCl, 10 mM BME pH20 °C = 6.5 buffer.
Protein sample was concentrated using Vivaspin 20 (Sartorius)
concentrator with 10,000 Da cutoff.
For expression of Rtt103141–246, bacterial culture was grown in
M9 medium with 50 mg/L ampicillin at 37 °C until OD600 ∼ 0.3,
cooled down to 25 °C, induced with 0.5 mM IPTG, and protein
was overexpressed at 25 °C overnight. Cells were harvested by
centrifugation and resuspended in the lysis buffer [50 mM Tris,
500 mM NaCl, 10 mM BME, 40 mM imidazole, 10% glycerol,
pH20 °C = 8 supplemented with protease inhibitor mixture (cOmplete;
Roche)]. After disruption of cells, the lysate was cleared by cen-
trifugation (50,000 × g for 1 h) and soluble fraction was loaded on
Ni-NTA column (Qiagen), washed with lysis buffer containing 1 M
NaCl and 75 mM imidazole, protein was eluted using lysis buffer
containing 500 mM imidazole. Eluted protein was loaded on
HiLoad 16/600 Superdex 75 (GE Healthcare) and eluted with
50 mM Tris, 500 mM NaCl, 5% glycerol, 10 mM BME, pH20 °C = 8.
Protein was dialyzed to 25 mM Tris, 200 mM NaCl, 1 mM BME,
pH4 °C = 8.0 and concentrated using Vivaspin 20 (Sartorius) con-
centrator with 3,000 Da cutoff to 6 mg/mL for crystallization.
Protein was crystallized in 3.75 M sodium formate at 20 °C. For
crystallization, the protein was labeled with selenomethionine
by feedback inhibition of the methionine biosynthesis pathway
in M9 media.
pET21b-Rtt103 was transformed into E. coli BL21-Codon Plus
(DE3)-RIPL cells (Stratagene). For the expression of Rtt103,
bacterial culture was grown in LB medium with 50 mg/L ampi-
cillin at 37 °C until OD600 ∼ 0.3, cooled down to 16 °C, induced
with 0.5 mM IPTG, and protein was overexpressed at 16 °C
overnight. Cells were harvested by centrifugation and resus-
pended in the lysis buffer [50 mM Tris, 500 mM NaCl, 10 mM
BME, 20 mM imidazole, pH20 °C = 8 supplemented with pro-
tease inhibitor mixture (cOmplete; Roche)]. After disruption of
cells, the lysate was cleared by centrifugation (50,000 × g for 1 h)
and soluble fraction was loaded on Ni-NTA column (Qiagen),
washed with lysis buffer containing 1 M NaCl, protein was eluted
using lysis buffer containing 500 mM imidazole. Eluted protein
was loaded on HiLoad 16/600 Superdex 200 (GE Healthcare)
and eluted with 50 mM Tris, 500 mM NaCl, 10% glycerol,
10 mM BME, pH20 °C = 8.
Size-Exclusion Chromatography Analysis. Molecular weight esti-
mation was performed using Superdex 200 10/300 GL column
in buffer containing 50 mM Tris, 250 mM NaCl, 1 mM BME,
pH20 °C = 8.0 at room temperature. Column was calibrated
using Gel Filtration Molecular Weight Markers Kit for Mo-
lecular Weights 12,000–200,000 Da (Sigma Aldrich).
Sample Preparation and SAXS Analysis. Rtt103141–246 was measured
in 50 mM Tris, 300 mM NaCl, 10 mM BME, pH = 8.0 (4 °C) with
1.9, 4.9, and 7 mg/mL concentration at 4 °C. Data from low and high
concentration measurements was merged. Rtt1031–246 was mea-
sured in 25 mM KH2PO4, 300 mM KCl, 10 mM BME, pH20 °C =
6.5 with 5.2 mg/mL concentration at 4 °C. Rtt1031–246–phospho-
mimetic complex was prepared by mixing phospho-mimetic
with 10-fold molar excess of Rtt1031–246. The formed complex
was purified using Superdex 200 Increase 10/300 (GE Health-
care) in 25 mM KH2PO4, 300 mM KCl, 10 mM BME, pH4 °C =
6.5. The peak fractions were pooled and concentrated on
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Amicon Ultra 0.5 mL Centrifugal filters (Millipore) with 3,000
Da cutoff. Dilution series were measured at 4 °C.
The SAXS data were collected on the BioSAXS-1000, Rigaku at
CEITEC. Data were collected at X-ray beam wavelength λ = 1.54 Å.
Sample to detector (PILATUS 100K; Dectris Ltd.) distance was
0.485 m, covering a scattering vector range from 0.008 to 0.65 Å−1.
For buffer and sample one 2D image was collected with an exposure
time of 60 min per image. Data are plotted using Gnuplot 4.6.
Evaluation of the solution scattering of the atomic models and the
fitting to experimental data were performed by CRYSOL (42). Ab
initio modeling was performed by DAMMIN (40). Superposition of
ab initio and atomic models was performed by SUPCOMB (43).
CORAL Modeling.Rigid body modeling was performed by CORAL
(33) using Rtt103141–246 crystal structure (PDB ID code: 5M48),
Rtt103-CID—pS2pS7-CTD complex structure (PDB ID code:
5M9D), protein sequences of phospho-serine mimetic and se-
quence of Rtt1031–246 as a constrain.
In CORALmodeling configuration setup each dimer ofRtt1031–246
was composed of two Rtt103-CIDs connected by 12-aa flexible
linker to the Rtt103141–246 coiled-coil dimer. The interaction be-
tween Rtt103-CID and the CTD stretch was restrained based on
the Rtt103-CID—pS2pS7-CTD complex structure, the nonbound
regions of CTD were kept flexible. Different arrangements of
CIDs were tested the calculation for each interaction scenario was
repeated 10 times.
EOM Modeling.Rtt1031–246 was modeled into SAXS experimental
data by EOM 2.0 (31) applying standard setup using Rtt103-CID
(PDB ID code: 2KM4), Rtt103141–246 (PDB ID code: 5M48) and
keeping unstructured elements flexible.
Fluorescence Anisotropy. The equilibrium binding of Rtt103 CID
and its mutants to different CTD-peptides was analyzed by FA.
The CTD peptides were N-terminally labeled with the 5,6-
carboxyfluorescein (FAM); for the list of peptides, see Table S5. The
measurements were conducted on a FluoroLog-3 spectrofluorome-
ter (Horiba Jobin-Yvon Edison). The instrument was equipped with
a thermostated cell holder with a Neslab RTE7 water bath (Thermo
Scientific). Samples were excited with vertically polarized light at
467 nm, and both vertical and horizontal emissions were recorded
at 516 nm. All measurements were conducted at 10 °C in 35 mM
KH2PO4, 100 mM KCl (pH 6.8). Each data point is an average of
three measurements. The experimental binding isotherms were
analyzed by DynaFit (44).
Crystal Structure Determination. Selenomethionine-containing crystals
were subjected to multiple anomalous dispersion diffraction ex-
periments. Specifically, the data were collected at the Se absorption
edge, at the inflection point, and at high and low energy remote
wavelengths. Data were processed and integrated using XDS
package (45). Unmerged XDS.ASCII file containing all of the re-
flections was processed by the program Pointless of CCP4 software
suit (46, 47), which resulted in the unambiguous F4132 space group
assignment. Reflections were scaled using the program Aimless (47)
of the CCP4 software suit. The same procedure was applied to all
four datasets. Scaled data were analyzed by the Xtriage module of
Phenix software suit (48), which indicated reliable anomalous signal
extended to 3.8 Å. The data were then subjected to heavy atom
search by the Hyss module of Phenix software suit while keeping
the resolution at 3.8 Å (49, 50). Four possible solutions were
found by Hyss (each containing six Se atoms) with a Hyss CC of
0.461. The correct solution was determined by calculating the
phase and carrying out density modification by programs SOLVE
and RESOLVE, respectively [both parts of Phenix software suit
(48, 51]. Correct solution statistics as described in ref. 52: Estimated
MAP CC × 100 = 65.13, SKEW of 0.37, FOM (figure of merit) =
0.551, R factor (of density modified map) of 0.331. The phases for
the protein model were calculated by the program SOLVE, and the
resulting density was further modified by the program RESOLVE
(51). Phasing was carried out at the resolution of 3 Å. The resulting
electron density was used for the automated model building
using the program Buccaneer of the CCP4 Software Suit (47,
53). This resulted in a model, which was deemed to be 90%
complete. Manual modifications included several Ramachan-
dran plot and rotamer outliers corrections using the program
Coot (54). The model was then used as a molecular replace-
ment search model to phase a dataset processed to 2.593 Å (low
energy remote) using Phaser (55). The resulting solution was
subjected to Phenix.Refine (56) module of Phenix crystallo-
graphic suit of programs (48). Individual XYZ coordinates and
individual B factors were refined and included TLS groups as
determined by TLS motion determination server, which resulted
in the overall crystallographic R and Rfree factors of 24.55% and
26.40%, respectively. Ramachandran-plot statistics: favored, 99%;
allowed, 1% as defined by wwPDB validation report.
NMR Measurements and Structure Determination. All NMR spectra
for the backbone and side-chain assignments were recorded on
Bruker AVANCE III HD 950, 850, and 700 MHz spectrometers
equipped with cryoprobes at a sample temperature of 20 °C using
1 mM uniformly 15N,13C-labeled Rtt103-CID in 35 mM KH2PO4,
100 mM KCl, pH 6.8 (20 °C) (90% H2O/10% D2O), and 2.5 mM
pS2pS7-CTD peptide. Initial nuclei assignment was transferred
from Biological Magnetic Resonance Bank entries 17044 and
16411 and confirmed by CBCACONH and HCCH-TOCSY
spectra. The structure of the complex was determined as pre-
viously described (30). Ramachandran-plot statistics: favored,
94%, allowed, 4%; outliers, 2% as defined by wwPDB valida-
tion report. Determination of chemical shift perturbation (CSP)
value was performed as previously described (30).
Trypsin Digestion and Mass-Spectrometry Analysis. For the limited
proteolysis study, 0.8 mg/mL Rtt103 was mixed with 50 ng/μL
trypsin (1:100 wt/wt; Promega). Samples were incubated at 20 °C
for 5, 10, 15, 30, 45, 60, 120 min and overnight. The cleavage
reaction was stopped by mixing with 4xSDS-gel loading dye and
5 min boiling at 95 °C. The samples were analyzed on 18% SDS/
PAGE. One-dimensional gel areas to be analyzed were excised
from the gel and after destaining and washing procedures, each gel
plug was incubated with trypsin (125 ng of trypsin, 2 h, 40 °C).
MALDI-MS and MS/MS analyses of tryptic digests were per-
formed on an Ultraflextreme mass spectrometer (Bruker Daltonik)
operated by FlexControl 3.3 software (Bruker Daltonik). Peptide
maps were acquired in reflectron positive mode (25 kV acceler-
ation voltage) with 800 laser shots. Peaks with minimum S/N =
10 were picked out for MS/MS analysis employing LIFT arrangement
with 600 laser shots for each peptide. α-Cyano-4-hydroxycinnamic
acid was used as the matrix in combination with AnchorChip
target. External mass calibration procedure was employed, using a
mixture of seven peptide standards (Bruker Daltonik) covering
the mass range of 700–3,100 Da. The FlexAnalysis 3.3 and MS
BioTools 3.2 (Bruker Daltonik) software were used for data pro-
cessing. MASCOT 2.2 (MatrixScience) search engine was used for
processing the MS and MS/MS data. For MALDI MS data, mass
tolerance of 30 ppm was allowed for peptide mapping and 0.5 Da
for MS/MS ion searches. Oxidation of methionine and propiona-
midylation of cysteine as optional modifications and one enzyme
miscleavage were set for all searches. Peptides with statistically
significant peptide score (P < 0.05) were considered. Manual MS/
MS spectra assignment validation was done.
Visualization of Structures and Preparation of Movies. Structures
were visualized and movies prepared using PyMOL (The PyMOL
Molecular Graphics System, Version 1.8 Schrödinger, LLC) or
UCSF Chimera (57).
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Fig. S1. Evaluation of Rtt103 structure by limited proteolysis. Trypsin digestion of Rtt103, which was recombinantly expressed in E. coli and purified to ho-
mogeneity, revealed a stable protein fragment of ∼30 kDa. The remaining C-terminal part (amino acids 247–409) was efficiently digested. (A) Limited pro-
teolysis study of the Rtt103 visualized on 18% SDS/PAGE. Sample of Rtt103 with addition of trypsin protease (+trypsin, Right) and the negative control
(−trypsin, Left); 5, 10, 15, 30, 45, 60, 120 min time points; molecular mass standards from Precision Plus Protein, Bio-Rad. (B) Image of 18% SDS/PAGE with
samples from A subjected to the subsequent MALDI-MS/MS analysis. The number of the sample is indicated on the Right. (C) Summary of the results of the
MALDI-MS/MS analysis. The sample number indicated on the Right corresponds to the number given on B. Blue boxes indicate the domain organization of
Rtt103 and known α-helical regions. Black vertical serifs continued as dashed vertical gray lines indicate predicted trypsin cleavage sites. Purple boxes indicate
peptides detected by trypsin digestion. Yellow boxes indicate peptides detected with low signal. Horizontal purple line indicates the presumed span of
Rtt103 fragment present in the gel bands.
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Fig. S2. Study of the Rtt103 coiled-coil domain. (A) Size-exclusion chromatography analysis of recombinant Rtt103 truncation constructs. A Superdex 200 10/
300 GL column was used. Void volume (V0), retention volumes, and molecular masses of the protein standards are indicated at the top (gray dashed lines).
(B) Evaluation of Rtt103141–246 experimental SAXS scattering data (black) against theoretical scattering data pertaining to the monomer (blue) and dimer (red)
structures derived by CRYSOL (42). (C) Crystal structure of the Rtt103141–246 coiled-coil domain with the characteristic coiled-coil region (defined by SOCKET
software; ref. 58). The residues that form the “knobs-into-holes” packing are highlighted according to the position in the classical coiled-coil heptad (abcdefg).
The zoom of the cross-sections from selected residues is shown at Lower. Respective N- and C-termini, as well as α-helices, of two polypeptide chains are
indicated. (D) Stereoview of the coiled-coil domain electron density map (2Fo−Fc density map contoured at 1.0 σ; gray mesh). (E) Multiple sequence alignment
of the dimerization domain region in Rtt103 homologs (S. cerevisiae, Q05543; A. gossypii, AAL081Cp; K. lactis, KLLA0C10758p; S. pombe, CAA21273.1;
C. albicans, CaO19.7662). Residues are colored according the hydrophobicity index. Alignment prepared in ClustalX (59), visualized in UCSF Chimera (57). The
coiled-coil region of S. cerevisiae Rtt103 is indicated in pink.
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Fig. S3. Solution NMR structure of the Rtt103 CID with the pS2pS7-CTD peptide. (A) Overlay of the 20 lowest-energy structures of the Rtt103 CID backbone (black ribbon) in complex with pS2pS7-CTD (red ribbon), shown in
stereoview. N- and C-termini are indicated. (B) Overlay of [1H15N]-HSQC spectra, with Rtt103 CID in free form (red) and bound to the pS2pS7-CTD peptide (blue). Region corresponding to the amides of protein (Left); region
corresponding to the Arg side chains (Right). (C) Schematic diagram of Rtt103 CID (blue labels) and pS2pS7-CTD (black) interactions. Hydrophobic contacts are indicated by spoked arcs, whereas hydrogen bonds are indicated
by dashed lines. The pS2pS7-CTD sequence used for structure determination is indicated at Upper, where residues that showed interaction with the Rtt103 CID are shown in black.
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Fig. S4. Binding affinities of Rtt103 CID mutants. (A) Equilibrium binding of Rtt103 CID with a 5,6-carboxyfluorescein-labeled TSPS Y(pS2)PTSPS Y(pS2)PTSPS
peptide (extrapS2-CTD) monitored by FA. (B) Plot with the quantified binding affinities (KD) of Rtt103 CID mutants toward the extrapS2-CTD peptide. Affinities
were measured by fluorescence anisotropy. Corresponding KD values (±SD of the fit) are shown. CID, CTD interacting domain. (C) Comparison of
1H-NMR
spectra that shows structural integrity of the Lys72Glu (purple), Arg116Glu (green), Gln19Ala (red), Ile112Gly (blue) mutants, and wild-type Rtt103 CID (yellow);
the region with NH backbone and side-chain resonances is shown. Data were collected on 700 and 850 MHz Bruker AVANCE III spectrometer at 293 K.































Fig. S5. Presence of the coiled-coil domain does not influence the structure of the Rtt103 CID. Overlay of [15N,1H]-TROSY spectra of Rtt1031–246 (blue) and
Rtt1031–131 (red), measured on a 950-MHz spectrometer. CID, CTD interacting domain.
Fig. S6. Glutamate substitution mimics CTD phosphorylation. To overcome production of high yields of homogeneously phosphorylated CTD, we prepared a
phospho-mimicking mutant of CTD where pS2 is substituted by a glutamate residue (Glu2, E). [
15N,1H]-HSQC titration data and binding studies confirmed that
the Rtt103 CID interacts similarly with the pS2-CTD peptide and the corresponding mutant pS2E-CTD. (A) Scheme showing a putative interaction (black dashed
line) between the Arg108 residue of Rtt103 and the E residue of pS2E-CTD (Left) or pS2 of pS2-CTD (Right). CTD peptides are shown as yellow sticks, whereas the
Rtt103 CID is shown as gray cartoons. The conformation of the glutamate residue was modeled using PyMOL, based on the structure with PDB ID code 2L0I.
(B) Binding affinities of the Rtt103 CID toward 5,6-carboxyfluorescein-labeled pS2, pS2E, and unphosphorylated CTD peptides, measured by fluorescence
anisotropy. (C) Chemical shift perturbations (CSP) of the Rtt103 CID upon interaction with pS2-CTD (blue) or pS2E-CTD (gray), plotted against residue numbers
corresponding to the Rtt103 CID sequence. Secondary structure elements are shown below the x axis; helices involved in the interaction with the phospho-
peptides are colored in black.
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Fig. S7. Multisubunit arrangement of Rtt1031–246 across half the length of the CTD. (A) Scheme of six different interaction scenarios (Left) used for CORAL
modeling. The order in which the CIDs bind the CTD (black ribbon) repeats is indicated by numbers. Ten CORAL runs were performed for each scenario, and a
representative model is shown for each (Right). (B) Table with values of goodness of the fit (χ2), radius of gyration (Rg), and maximum intraparticle distance
(Dmax) for each CORAL run of each interaction scenario. Scenarios 1–6 correspond to those in A, whereas scenario 0 corresponds to that shown in Fig. 3. The
values of Rg and Dmax are determined using CRYSOL (42) for each CORAL model.
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Table S1. Data collection and phasing for the structure of the construct Rtt103141–246
Data collection Peak Inflection High-energy remote Low-energy remote
Space group F4123 F4123 F4123 F4123
Cell dimensions
a, b, c, Å 217.14, 217.14, 217.14 217.14, 217.14, 217.14 217.14, 217.14, 217.14 217.14, 217.14, 217.14
α, β, γ, ° 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90
Wavelength 0.979 0.9792 0.9713 0.9919
Resolution, Å 63.18–2.65 (2.74–2.65) 63.18–2.65 (2.74–2.65) 63.09–2.60 (2.69–2.60) 54.54–2.59 (2.70–2.59)
Rsym, % 15.8 (192) 16.1 (187) 35 (485) 21.6 (306)
I / σI 23.2 (2.0) 25.9 (2.4) 21.6 (1.3) 21.9 (1.7)
Completeness, % 99.9 (99.3) 99.9 (99.2) 100 (99.9) 100 (99.9)
Redundancy 27.8 37.0 46.8 29.7
Values in parentheses are for highest-resolution shell.
Table S2. Refinement statistics for the structure of the construct
Rtt103141–246











Bond lengths, Å 0.021
Bond angles, ° 0.463
Table S3. NMR distance and dihedral constraints for the
complex between the Rtt103 CID and the pS2pS7-CTD peptide





Sequential (ji – jj = 1) 1,667
Nonsequential (ji – jj > 1) 1,897
Hydrogen bonds 96
Intermolecular distance restraints 49




*α-helical dihedral angle restraints imposed for the backbone based on the
CSI.
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Table S4. Structure statistics for the complex between the Rtt103 CID
and the pS2pS7-CTD peptide
Structure statistics Value
Violations (mean and SD)
Distance constraints (>0.4 Å) 0.1 ± 0.31
Dihedral angle constraints (>15º) 15.05 ± 1.6
Max. dihedral angle violation, º 52 ± 11
Max. distance constraint violation, Å 0.31 ± 0.05
Deviations from idealized geometry
Bond lengths, Å
Bond angles, º 1.5 ± 0.022
Average pairwise rmsd,* Å
Rtt103 CID (7-12; 19-31; 54-73; 77-94; 100-116; 121-133)
Heavy atoms 1.13 ± 0.16
Backbone atoms 0.41 ± 0.16
CTD (141–150)
Heavy atoms 2.38 ± 0.57
Backbone atoms 1.17 ± 0.33
Complex
All heavy atoms 2.23 ± 0.43
All backbone atoms 1.77 ± 0.46
*Pairwise rmsd was calculated among 20 refined structures.
Table S5. List of peptides used in the study
Name
(Label)-sequence
(N to C terminus) Synthesis company Description/use
pS2pS7-CTD TSP(pS) Y(pS)PTSP(pS) Y(pS)PTS Clonestar Solution NMR structure determination
FAM-extrapS2-CTD FAM-TSPS Y(pS)PTSPS Y(pS)PTSPS Clonestar Fluorescence anisotropy measurements;
NMR titration
FAM-pS2-CTD FAM- Y(pS)PTSPS Y(pS)PTSPS Clonestar Fluorescence anisotropy measurements;
NMR titration
FAM-CTD FAM- YSPTSPS YSPTSPS Clonestar Fluorescence anisotropy measurements
FAM-short pS2pS7-CTD FAM- SPS Y(pS)PTSP(pS) YS Clonestar Fluorescence anisotropy measurements
FAM-long pS2pS7-CTD FAM- SPS Y(pS)PTSP(pS) YSPTSPS
Y(pS)PTSP(pS) YS
Clonestar Fluorescence anisotropy measurements
FAM-pS7 FAM- YSPTSP(pS) YSPTSP(pS) Clonestar Fluorescence anisotropy measurements
FAM-pS2E-CTD FAM- YEPTSPS YEPTSPS Clonestar Fluorescence anisotropy measurements
pS2E -CTD YEPTSPS YEPTSPS Clonestar NMR titration
pS2-CTD Y(pS)PTSPS Y(pS)PTSPS Clonestar NMR titration
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Table S6. Oligonucleotides used in the study
Name Sequence (5′ to 3′) Description/use
Rtt103_141_NdeI_forw CAGCATATGTTGGTGTTACCCCAG Forward primer for cloning of Rtt103141–246
into pET22b
Rtt103_246_XhoI_rev CACCTCGAGGTCTTTAGCAGATAAAAC Reverse primer for cloning of Rtt103141–246
into pET22b
Rtt103_246_forw GTTTTATCTGCTAAAGACCTCGAGCACCACCACCACCACC Forward primer for cloning of Rtt1031–246
Rtt103_246_rev GGTGGTGGTGGTGGTGCTCGAGGTCTTTAGCAGATAAAA C Reverse primer for cloning of Rtt1031–246
Rtt103_R108E_forw GGGACCTAAAAAAGAAGTTGTCAGAAGTTGTGAATATAC Forward primer for Rtt103-CID R108E mutant
Rtt103_R108E_rev GTATATTCACAACTTCTGACAACTTCTTTTTTAGGTCCC Reverse primer for Rtt103-CID R108E mutant
K72E_forw CATGTTGTTCAACAGGCTGAAGGTCAAAAAATTATTC Forward primer for Rtt103-CID K72E
and K72E/R116E mutant
K72E_rev GAATAATTTTTTGACCTTCAGCCTGTTGAACAACATG Reverse primer for Rtt103-CID K72E and
K72E/R116E mutant
Rtt103_R116E_forw GTGAATATACTAAAAGAAGAGAATATATTTTCCAAGCAGG Forward primer for Rtt103-CID R116E and
K72E/R116E mutant
Rtt103_R116E_rev CCTGCTTGGAAAATATATTCTCTTCTTTTAGTATATTCAC Reverse primer for Rtt103-CID R116E
and K72E/R116E mutant
sCTD universal Bam HI forw CGTGGATCCCCGGAATTCACCTG Forward primer for cloning of
phophomimicking CTD into pET28b-SMT3
sE2 13 FLAG HindIII rev GGAAGCTTACTTATCGTCGTCATCCTTGTAATCTGCTGCTGCTGGTTCATA Reverse primer for cloning of
phophomimicking CTD into pET28b-SMT3
Movie S1. The two CIDs tethered to the coiled-coil domain tumble independently. The SAXS data were combined with available atomic-resolution structures
(PDB ID codes: 2KM4, 5M48) using the ensemble-optimization method (EOM 2.0) to yield the conformational distribution of CID- and coiled-coil-domain
arrangements. The movie starts with the overlay of individual conformers (Fig. 3) obtained from the ensemble of Rtt1031–246 structures derived by EOM 2.0.
These conformers are then displayed in sequence one after another. Then the morph that shows conversion from conformer 1 to conformer 5 is shown and
rotated. The movie ends with the overlay of all conformers, where conformers 2 through 5 are shown with lower opacity. The two different polypeptide chains
forming the dimer are shown in red and blue. The conformers are superimposed relative to the coiled-coil domain. In the resulting model, the coiled-coil
domain defines the length of the protein. Connection via the 15-amino acid linker allows the CIDs to be positioned relatively close to each other but also to
reach all across the coiled-coil domain and sample a large surrounding space to recognize the substrate. The ability of the CIDs to sample multiple confor-
mations is restricted only by their tethering to the flexible linker. The movie was prepared using UCSF Chimera (57).
Movie S1
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Movie S2. Model of the Rtt103-CTDsome assembly involving the full-length RNAPII CTD. The model of RNAPII (Fig. 4) with the full-length CTD (26 repeats,
budding yeast) is decorated with six Rtt1031–246 dimers. The structure of RNAPII (PDB ID: 5F12) is combined with two CORAL models of the Rtt1031–246-CTD
complex, where the CTD-interacting domains (CIDs) are arranged in a consecutive manner. The movie was prepared using UCSF Chimera (57).
Movie S2
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